Pharmacogenomics of Fluorouracil, Irinotecan, and Oxaliplatin in Hepatic Metastases of Colorectal Cancer: Clinical Implications

Author： Lentz Frederike   Tran Agnès   Rey Elisabeth   Pons Gérard   Tréluyer Jean-Marc  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.5, Iss.1, 2005-01, pp. : 21-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics of 5-Fluorouracil/Oxaliplatin in Colorectal Cancer

By  

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 277-283

Bentham Science Publishers

Access to resources Recommend Favorite

Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer

By Cao Shousong   Bhattacharya Arup   Durrani Farukh A   Fakih Marwan  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 687-703

Informa Healthcare

Access to resources Recommend Favorite

Irinotecan plus fluorouracil and folinic acid should be the comparator regimen in clinical trials involving patients with metastatic colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1232, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Oxaliplatin + fluorouracil the new standard in colorectal cancer?

By  

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

A review of oxaliplatin and its clinical use in colorectal cancer

By Grothey Axel   Goldberg Richard M  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2159-2170

Informa Healthcare

Access to resources Recommend Favorite